Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement - 3rd Quarter

13 Aug 2019 15:19

RNS Number : 9065I
Income & Growth VCT (The) PLC
13 August 2019
 

The Income & Growth VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2019

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 June 2019. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

 

At 30 June 2019

At 31 March 2019

 

Net assets attributable to shareholders

£84,211,371

£81,438,038

Shares in issue

103,827,380

104,363,865

Net asset value (NAV) per share

81.11p*

78.03p

Cumulative dividends paid to date per share

111.50p*

111.50p

Total return per share since inception (NAV basis)

192.61p

189.53p

*Figures are quoted prior to the 1.50 pence dividend referred to below.

 

INTERIM DIVIDEND

 

The Board declared an interim dividend of 1.50 pence per share for the year ending 30 September 2019, comprising 1.00 penny and 0.50 pence from capital. This dividend was paid to shareholders on 12 July 2019 to shareholders on the Register on 14 June 2019 and brings cumulative dividends paid per share to 113.00 pence per share, and also reduces the Company's Net Asset Value by a corresponding amount.

 

SHARE BUYBACKS

 

On 5 June 2019, the Company purchased 300,000 of the Company's own ordinary shares at a price of 67.50 pence per share for cancellation.

 

On 7 June 2019, the Company purchased 236,485 of the Company's own ordinary shares at a price of 70.25 pence for cancellation.

 

After the period end, with effect from 1 August 2019, the Board changed its share buyback policy objective of maintaining the discount to Net Asset Value at which the Company's shares may trade in the market from approximately 10% or less, to approximately 5% or less. In pursuing this policy, the Board's priority will remain to ensure that it is acting prudently and in the interests of the remaining shareholders of the Company. Share buybacks will continue to be entirely at the Board's discretion and will be subject to the Company having sufficient funds available for such a purpose. They will also continue to be subject to prevailing market conditions, the Listing Rules and any applicable law and regulatory restrictions at the relevant time. Shares bought back in the market will ordinarily be cancelled.

 

INVESTMENT ACTIVITY

 

Investments during the period

On 13 May 2019, the Company invested £1.53 million into a new investee company, Arkk Consulting, which provides services and software to enable organisations to remain compliant with regulatory reporting requirements.

 

On 22 May 2019, the Company invested £0.93 million into a new investee company, Parsley Box, which is a UK direct to consumer supplier of home delivered ambient ready meals for the elderly.

 

Realisations during the period

On 10 May 2019, the Company sold its remaining investment in Plastic Surgeon to Polygon Group for £1.22 million. Over the eleven years this investment was held, it generated proceeds of £2.27 million compared to an original investment cost £0.41 million, which is a multiple on cost of 5.6 x and an IRR of 20.5%.

 

On 28 June 2019, the Company sold its investment in ASL Technology for £4.79 million. Over the eight and a half years this investment was held, it generated proceeds of £5.94 million compared to an original investment cost of £2.72 million, which is a multiple on cost of 2.2x and an IRR of 12.6%.

 

Transactions after the period end

After the period end, the Company made a follow-on investment of £0.62 million into MPB Group, a leading online marketplace for camera and video equipment.

 

On 2 August 2019, £0.17 million of contingent consideration was received as part of the sale of Entanet Holdings in August 2017.

On 6 June 2019, the Company realised part of its investment in Master Removers Group generating proceeds receivable of £0.51 million, as part of a transaction which also increased the Company's equity interest from 6.3% to 9.6%.

 

PLANNED FUNDRAISING

As announced recently, the Board intends to launch offers for subscription for new ordinary shares in the autumn, full details of which will be contained in the prospectus that will be sent to all registered shareholders.

 

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

 

For further information, please contact:

Rob Brittain, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUORSRKKAWAAR
Date   Source Headline
20th Dec 20194:00 pmRNSFundraising Update
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
16th Dec 20199:45 amRNSTransaction in Own Shares
13th Dec 20194:30 pmRNSAnnual Financial Report
6th Dec 20194:45 pmRNSDividend Investment Scheme - Recommencement
6th Dec 20194:45 pmRNSAnnual Results for the year ended 30 Sep 2019
26th Nov 20194:09 pmRNSDirector Declaration
14th Nov 201912:00 pmRNSFundraising Update
12th Nov 20192:30 pmRNSDirectorate Change
25th Oct 20194:00 pmRNSPublication of a Prospectus
18th Oct 20195:20 pmRNSDirectorate Change
3rd Oct 20199:52 amRNSDirector Declaration
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
18th Sep 20194:01 pmRNSDividend Declaration
10th Sep 20195:00 pmRNSFundraising Update, Circular and General Meetings
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
13th Aug 20193:19 pmRNSInterim Management Statement - 3rd Quarter
31st Jul 20197:00 amRNSReduction of Capital
29th Jul 201911:00 amRNSShare buyback policy objective
29th Jul 20197:00 amRNSIntention to launch offers for subscription
2nd Jul 20199:11 amRNSRealisation of investment
7th Jun 20195:35 pmRNSTransaction in Own Shares
5th Jun 20194:44 pmRNSTransaction in Own Shares
4th Jun 201911:05 amRNSHalf-year Report
30th May 20193:38 pmRNSHalf-year Report
26th Mar 20195:25 pmRNSTransaction in Own Shares
15th Feb 20194:30 pmRNSTransaction in Own Shares
6th Feb 20191:54 pmRNSInterim Management Statement - 1st Quarter
6th Feb 20191:42 pmRNSResult of AGM
19th Dec 20184:32 pmRNSTransaction in Own Shares
19th Dec 20183:50 pmRNSAnnual Financial Report
17th Dec 20189:25 amRNSTransaction in Own Shares
12th Dec 20182:25 pmRNSDividend Investment Scheme - Suspension
12th Dec 20182:24 pmRNSFinal Results for year ended 30 September 2018
26th Sep 20184:54 pmRNSTransaction in Own Shares
13th Sep 201811:59 amRNSInterim Management Statement to 30 June 2018
14th Aug 20189:42 amRNSNet Asset Value(s)
20th Jul 20185:41 pmRNSTransaction in Own Shares
2nd Jul 20184:18 pmRNSTotal Voting Rights
21st Jun 20184:24 pmRNSDirector/PDMR Shareholding
21st Jun 20184:20 pmRNSDirector/PDMR Shareholding
21st Jun 20184:19 pmRNSIssue of Equity
11th Jun 201811:13 amRNSTransaction in Own Shares
15th May 201812:59 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.